PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University Torun, University Hospital, Bydgoszcz, Poland.\', \'Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.\', \'Department of Haematology and Medical Oncology, Clinic for Internal Medicine II, University Hospital Jena, Jena, Germany, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute, Jena, Germany.\', \'Haematology Unit, Department of Research and Clinical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.\', \'Department of Hematology and Transplantation, Medical University Poznan, Poland.\', \'Infectious Diseases Unit, Department of Internal Medicine, San Martino Policlinico Hospital-IRCCS for Oncology and Neurosciences, Genoa, Italy.\', \'Infectious Diseases Unit, Department of Health Sciences [DISSAL], University of Genoa, Genoa, Italy.\', \'Infectious Disease Working Party EBMT Data Office, University of Leiden, Leiden, The Netherlands.\', \'Faculty of Medicine, Department of Pediatric Infectious Diseases, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.\', \'Department of Hematology, Hospital de la Princesa, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/tid.13773
?:hasPublicationType
?:journal
  • Transplant infectious disease : an official journal of the Transplantation Society
is ?:pmid of
?:pmid
?:pmid
  • 34918856
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all